NCT07687888Not yet recruiting
Pharmacy-based Provision of Pre-exposure Prophylaxis (PrEP) for Adolescent Girls and Young Women in Tanzania
MWOTAJI: Making Women's Options for HIV Prevention In Tanzania Accessible, and Joining in Implementation Science Capacity Building
Source: ClinicalTrials.gov · Last updated 22 Jul 2026
Brief summary (registry, in English)
Implementation study comparing standard pre-exposure prophylaxis (PrEP) services to four models of pharmacy-based PrEP access for young women aged 18-24 (YW) in Tanzania. At 9 months, all sites converge to one pharmacy-based PrEP model and are randomly allocated to one of two cost sharing models to increase the program's potential for sustainability.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 2818 (estimated)
- First submitted
- 30 Jun 2026
- Start date
- Sept 2026
- Primary completion date
- Feb 2028
- Lead sponsor
- Mzumbe University - Centre of Excellence in Health Monitoring and Evaluation
- Diseases
- HIV
- NCT number
- NCT07687888
What you commit to
- Study type: Interventional
- Planned participants: 2818
- From Sept 2026 to the primary completion date, Feb 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Female sex;
- Age 18-24 at the baseline visit;
- Living in one of five study sites in Shinyanga, Geita or Kagera regions of Tanzania with no known plans to move;
- Interested in starting PrEP;
- Access to a mobile phone (either own phone or borrowed phone); and
- Eligible for PrEP based on Tanzania National PrEP Guidelines behavioral screening criteria
- Female sex;
- Age 18-24; and
- Living in one of five study sites in Shinyanga, Geita or Kagera regions of Tanzania.
- Geographically located within one of five study sites in Shinyanga, Geita or Kagera regions of Tanzania;
- Located within 4 km of at least 1 health facility that provides PrEP services and whose lab conducts creatinine and hepatitis B testing;
- Has no planned extended closures over the next 24 months.
- Pharmacy owners and staff affiliated with study pharmacies; and
- ≥18 years of age.
- Staff employed at referral health facilities within one of five study sites in Shinyanga, Geita or Kagera regions of Tanzania or local, regional, or national government officials;
- ≥18 years of age.
Age in the registry: 18 years to 24 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Health for a Prosperous Nation Coordinator of this site? Confirm its status | Dar es Salaam | Tanzania | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.